Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
3(25%)
Results Posted
11%(1 trials)

Phase Distribution

Ph phase_4
6
50%
Ph phase_3
1
8%
Ph not_applicable
2
17%
Ph phase_2
3
25%

Phase Distribution

0

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
3(25.0%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
6(50.0%)
N/ANon-phased studies
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(9)

Detailed Status

Completed9
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (25.0%)
Phase 31 (8.3%)
Phase 46 (50.0%)
N/A2 (16.7%)

Trials by Status

recruiting325%
completed975%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12